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Background: Tibial dyschondroplasia (TD) is a common skeletal disorder in broiler chickens. It is characterized by
the presence of a non-vascularized and unmineralized cartilage in the growth plate. Previous studies have
investigated differential expression of genes related to cartilage development during latter stages of TD. The aim of
our study was to identify differentially expressed genes (DEGs) in the growth plate of broiler chickens, which were
associated with early stage TD. We induced TD using tetramethylthiuram disulfide (thiram) for 1, 2, and 6 days and
determined DEGs with chicken Affymetrix GeneChip assays. The identified DEGs were verified by quantitative
polymerase chain reaction (qPCR) assays.
Results: We identified 1630 DEGs, with 82, 1385, and 429 exhibiting at least 2.0-fold changes (P < 0.05) at days 1, 2,
and 6, respectively. These DEGs participate in a variety of biological processes, including cytokine production,
oxidation reduction, and cell surface receptor linked signal transduction on day 1; lipid biosynthesis, regulation of
growth, cell cycle, positive and negative gene regulation, transcription and transcription regulation, and anti-
apoptosis on day 2; and regulation of cell proliferation, transcription, dephosphorylation, catabolism, proteolysis,
and immune responses on day 6. The identified DEGs were associated with the following pathways: neuroactive
ligand-receptor interaction on day 1; synthesis and degradation of ketone bodies, terpenoid backbone biosynthesis,
ether lipid metabolism, JAK-STAT, GnRH signaling pathway, ubiquitin mediated proteolysis, TGF-β signaling, focal
adhesion, and Wnt signaling on day 2; and arachidonic acid metabolism, mitogen-activated protein kinase (MAPK)
signaling, JAK-STAT, insulin signaling, and glycolysis on day 6. We validated seven DEGs by qPCR.
Conclusions: Our findings demonstrate previously unrecognized changes in gene transcription associated with
early stage TD. The DEGs we identified by microarray analysis will be used in future studies to clarify the molecular
pathogenic mechanisms of TD. From these findings, potential pathways involved in early stage TD warrant further
investigation.Background
Tibial dyschondroplasia (TD) is a common skeletal dis-
order in broiler chickens characterized by the presence
of non-vascularized and unmineralized cartilage in the
growth plate. Tetramethylthiuram disulfide (thiram)
exerts its cytotoxic effects through membrane damage,
mitochondrial injury, inhibition of glutathione metabo-
lism, cell death, and inhibition of angiogenesis. Rath* Correspondence: hlgdz@163.com
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reproduction in any medium, provided the oret al. [1] showed that thiram-induced TD is not pro-
duced through an increase in chondrocyte multiplica-
tion in the transition zone, nor by altering the
expression of genes causing the arrest of chondrocytes
in a pre-hypertrophic state. It acts by creating metabolic
dysfunction that leads to the destruction of blood capil-
laries in the transition zone chondrocytes. Our previous
studies showed that thiram could promote chondrocyte
proliferation in the growth plate of chickens, and disturbs
the regulation of endochondral calcification and develop-
ment of normal cartilage. This results in prehypertrophic
cell accumulation, angionecrosis, abnormal extracellular. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Figure 1 Histologic characteristics of tibia growth plate development in broiler chickens at day 4 during the experimental period.
C, control; T, thiram-fed; A, articulus zone; P, proliferative zone; PH, pre-hypertrophic zone; H, hypertrophic zone; Ca, calcification zone. Thiram
promoted chondrocyte proliferation, resulting in necrosis of a large number of cells, and compressed blood vessels that led to necrosis of blood
vessels. The scale bar indicates 200 μm.
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bone resorption (Figure 1) [2].
Previous studies have investigated the differential expres-
sion of genes related to cartilage development during late
stage TD using various techniques, such as immunohisto-
chemistry, western blotting, in situ hybridization, semi-
quantitative polymerase chain reaction (PCR), real-time
quantitative PCR (qPCR), and proteomic analyses. These
studies revealed abnormal expression of a variety of factors
during TD, including extracellular matrix molecules
(collagen, osteopontin, osteonectin), growth factors, and
hormones [vascular endothelial growth factor (VEGF)
and its receptor, hypoxia inducible factor-1 (HIF-1)].
Additionally, matrix metalloproteinases (MMPs), carbonic
anhydrase II (CA2), and heat shock proteins (HSPs) were
also shown to be affected [3-11]. Recently we generated
cDNA libraries for 96-h thiram-induced broiler chicken
TD using a suppression subtractive hybridization (SSH)
technique, and identified 10 differentially expressed genes
(DEGs). Five of these DEGs were found to be upregulated
in chicken TD: matrilin-3 (matn3); chondromodulin-I
(chm-1); NADH dehydrogenase (nadhdh); cytochrome C
oxidase subunit III (coxIII); and enolase 1 (eno1). Differen-
tial expression of these genes may affect cartilage matrix
cross-linking, angiogenesis, energy metabolism, and
growth regulation [12]. The average cycle of chondrocyte
proliferation to terminal differentiation is approximately
21 h; with thiram-induced cytotoxicity accompanied byrapid and significant oxidation, lipid peroxidation, and cell
death. Thus, it is likely that the changes that occur during
the early stages of TD initiate alterations that are found
during late stage TD.
The use of DNA microarray techniques has made it pos-
sible for large-scale analysis of gene function and regula-
tion to be conducted. DNA microarrays have been used to
study skeletal development in humans and rodents
[13-15]. In this study, we screened temporal changes in
DEGs during early stages of TD in broiler chickens using
an Affymetrix GeneChip, and verified expression patterns
at different phases by qPCR. Genetic analyses were used to
complement morphological changes and better under-
stand the pathogenic mechanisms of TD.
Results
Pathological features of thiram-induced TD
Pathologic characteristics of broiler chicken tibia growth
plate induced by thiram at day 1 were ascertained (Figure 2).
Macroscopic examination revealed that the growth plates
of chickens administered thiram were thickened compared
with the control group (Figure 2a). Histological characteris-
tics of the growth plates of these chickens were observed
by microscopy, and revealed that chondrocytes at the thick-
ened proliferative and pre-hypertrophic zones were sparse.
Pre-hypertrophic and hypertrophic chondrocytes exhibited
pyknosis. Additionally, the number of empty cartilage cap-
sules was increased and the number of blood vessels
Figure 2 Pathological characteristics of tibia growth plates due to thiram at day 1. C, control group; T, thiram-fed group. a. Compared with
the control group, the growth plate of thiram-treated chickens was thicker. b. Histological characteristics of the growth plate of chickens
fed thiram. The scale bar indicates 200 μm. A, Articulus zone; P, proliferative zone; PH, pre-hypertrophic zone; H, hypertrophic zone. Chondrocytes
at the thickened proliferative and prehypertrophic zones were sparse. Pre-hypertrophic and hypertrophic chondrocytes exhibited pyknosis.
The number of empty cartilage capsules was increased, while the number of blood vessels was reduced, with angionecrosis seen at the
pre-hypertrophic zone. c. Possible apoptotic cells are shown with pyknotic nuclei, enlarged dilated cisternae of the ER that formed a continuous
network, and concentrated cytoplasm. The scale bar indicates 1 μm.
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hypertrophic zone (Figure 2b). Transmission electron mi-
croscopy was used to examine apoptotic cells that contained
pyknotic nuclei. These cells exhibited dilated cisternae of
the endoplasmic reticulum (ER) that were enlarged and
formed a continuous network, with a concentrated cyto-
plasm (Figure 2c).
Isolation and assessment of total RNA
Total RNA was isolated from the growth plates of con-
trol and thiram-treated chickens on days 1, 2 or 6 post-
feeding. Total RNA quality was determined sufficient for
subsequent analyses when RNA integrity was 2 (distinct
bands corresponding 28S and 18S rRNA at a ratio of 2:1),
total RNA concentration was between 2–4 μg/μL, the
A260/280 ratio was around 2.1, and the A260/230 ratio of a
sample was near 2.2.
DEGs at different stages of TD
Our one-way ANOVA revealed 1630 DEGs with a mini-
mum 2.0-fold change (p < 0.05) in expression level.
There were 82, 1385, and 429 DEGs identified on days 1, 2,
and 6, respectively (Additional file 1). On day 1, 61 DEGswere upregulated and the remaining 21 downregulated. On
day 2, 641 DEGs were upregulated and 744 downregulated,
while on day 6, 324 DEGs were upregulated and 105
downregulated. Only 29 DEGs were commonly observed at
all three time points; 18 DEGs were observed for both days
1 and 2; 13 DEGs were observed on days 1 and 6; and 177
DEGs were commonly observed for days 2 and 6 (Figure 3).
And there were 39, 1086, and 279 DEGs (2.0-fold change,
p < 0.05) identified on days 1, 2, and 6 by two-way
ANOVA (Additional file 2).
Reliability of microarray screening
Microarray screening assays revealed 18 hybridization
maps. All maps showed a regular dot array with excellent
signal saturation and homogeneous background. Quality
control reports also indicated a stable background
around 30, and a noise level of 1.14%. At the experimen-
tal setting (α1 = 0.04, α2 = 0.06, τ = 0.015), the marginal
signal intensity (M) was approximately 2.2%, thereby
confirming the reliability of the microarrays.
To further validate the microarrays, seven up-regulated
genes (1.3–73.5-fold) were selected for qPCR analysis. Of
these genes, heat shock protein 25 (hsp25), and lysyl
Figure 3 Analysis of the 1630 transcripts identified on days 1, 2
and 6 using Venn diagrams. 1C, 2C, and 6C indicates days 1, 2 and
6 for the control group, respectively, while 1T, 2T, and 6T denotes days
1, 2, and 6 for the thiram-fed group, respectively. There were 82, 1385,
and 429 DEGs identified on days 1, 2, and 6, respectively. Only 29 DEGs
were observed at all three time points. Thirteen DEGs were observed
on both days 1 and 6; 18 DEGs were observed on both days 1 and 2;
177 DEGs were observed on both days 2 and 6.
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(p < 0.05) at days 1, 2 and 6. However, kinectin 1 (ktn1),
inhibitor of DNA binding 1 (id-1), secreted frizzled-
related protein 4 (sfrp4), cadherin 1 (cdh1), and enolase
2 (eno2) showed significant (p < 0.05) differential ex-
pression at two time points. Despite consistent trends of
differential expression, the qPCR results did not agree
with the microarray data with respect to the range in
fold-change (FC) range (Table 1).Table 1 Validation of microarray data by qPCR
Gene Gene description Micr
d 1
lox lysyl oxidase +3.9
hsp25 heat shock protein 25 +2.1
id1 inhibitor of DNA binding 1 +1.6 a
ktn1 kinectin 1 +1.5 a
sfrp4 secreted frizzled-related protein 4 +2.8
cdh1 cadherin 1 +1.3 a
eno2 enolase 2 +2.3
+ Represents upregulated. a Represents p > 0.05; d1, d2, and d6 denote the three tCluster analyses of DEGs
Principal component analysis (PCA) revealed a similarity
of 37.7% at the three time points examined. There was a
relatively minor difference in DEGs observed between
control and thiram-fed chickens at day 1. However, the
differences in DEGs between the two groups were sig-
nificantly different at days 2 and 6 (Figure 4). A clear ex-
pression pattern emerged after hierarchical clustering
analyses of the 1630 transcripts (p < 0.05, FC ≥ 2.0) on
days 1, 2, and 6. Hierarchical cluster analysis also
showed that chickens in the control group on days 1, 2,
and 6 formed a cluster with similar gene expression pat-
terns. Gene expression patterns of thiram-fed chickens
on days 1 and 6 were more similar to those observed in
control animals. The gene expression patterns in thiram-
fed chickens at day 2 formed a separate cluster with
similar gene expression patterns (Figure 5).DEGs gene ontology (GO) analyses
Annotation of identified DEGs was carried out using the
Database for Annotation, Visualization and Integrated
Discovery (DAVID) at the three time points examined.
These DEGs were found to participate in a variety of bio-
logical processes, such as cytokine production (p < 0.05),
cell adhesion, intracellular signaling cascades, cell surface
receptor linked signal transduction, oxidation reduction
and phosphate metabolic processes on day 1 (Figure 6).
On day 2 DEGs were associated with transcription regu-
lation, sterol metabolic processes, lipid biosynthetic pro-
cesses, growth regulation, steroid metabolism, regulation
of cell morphogenesis, the mitotic cell cycle, fatty acid
metabolism, cellular amino acid derivative metabolism,
anti-apoptosis, the cell cycle, positive and negative gene
regulation (p < 0.05) (Figure 7). On day 6, DEGs were as-
sociated with positive regulation of the developmental
process, transcription, immune responses, bone minera-
lization and positive regulation of cell differentiation
(p < 0.01), proteolysis, protein amino acid dephosphoryla-
tion, negative regulation of signal transduction, regulationoarray FC qPCR FC
d 2 d 6 d1 d2 d6
+71.8 +9.6 +4.4 +212.9 +13.8
+43.3 +25.1 +3.4 +298.0 +30.5
+2.9 +2.3 +1.1 a +1.8 +1.2 a
+4.7 +3.6 +1.9 a +17.1 +5.7
+73.5 +11.6 +2.0 a +52.2 +11.2
+31.4 +10.9 +2.4 a +45.4 +3.1
+10.5 +4.0 +5.1 +6.2 +1.1 a
ime points of analysis.
Figure 4 PCA analysis. PCA mapping indicated 37.7% similarity at the three time points. The insignificant difference between 1T and 1C
indicated that the number of DEGs was small at day 1, with a much greater difference observed at days 2 and 6.
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cation, and catabolic processes (p < 0.05) (Figure 8).
Potential metabolic pathways related to TD
A number of metabolic pathways were possibly related
to TD development between days 1 and 6. Pathways as-
sociated with DEGs were: neuroactive ligand-receptor
interaction (p < 0.05); the phosphatidylinositol signaling
system; calcium signaling pathways; and the MAPK sig-
naling pathway on day 1. Synthesis and degradation of
ketone bodies, ether lipid metabolism, terpenoid back-
bone biosynthesis, JAK-STAT, and steroid biosynthesis
(p < 0.05), GnRH signaling pathway, ubiquitin mediated
proteolysis, TGF-β signaling, MAPK signaling, VEGF
signaling, focal adhesion, Wnt signaling, and regula-
tion of the actin cytoskeleton were all pathways asso-
ciated with DEGs identified on day 2. Arachidonic
acid metabolism (p < 0.01), the MAPK signaling path-
way (p < 0.05), JAK-STAT, glycolysis, Adipocytokine
signaling pathway, insulin signaling, cytokine-cytokine
receptor interaction, TGF-β signaling, focal adhesion
and regulation of the actin cytoskeleton were associated
with DEGs on day 6. Of these DEGs, the expression
level of secreted frizzled-related protein 4 (sfrp4) wasupregulated 2.8-, 73.5-, and 11.6-fold on days 1, 2, and
6, respectively. The expression level of cadherin 1
(cdh1) was upregulated 31.4- and 10.9-fold on days 2
and 6, respectively. Similarly, expression of enolase 2
(eno2) was upregulated 2.3-, 10.5-, and 4.0-fold on days
1, 2, and 6, respectively.
Discussion
Previous studies of TD have focused on the late stages;
however, in this study we have reported the pathological
changes of thiram-induced TD at earlier stages. Our find-
ings show that the growth plate in chickens given thiram
was thickened, with a decreased number of chondrocytes
at the thickened proliferative and pre-hypertrophic zone.
The pre-hypertrophic and hypertrophic chondrocytes
exhibited pyknosis. We also observed an increased num-
ber of empty cartilage capsules and a decreased number
of blood vessels, in addition to angionecrosis at the pre-
hypertrophic zone. Transmission electron microscopy
analysis of apoptotic cells revealed pyknotic nuclei, and di-
lated cisternae of the ER that were enlarged and formed a
network structure; also, the cytoplasm was concentrated.
Biological process annotation revealed that the DEGs
at day 1 following feeding with the thiram diet were
Figure 5 Hierarchical clustering analysis of differentially expressed genes during TD. Hierarchical clustering analyses of the 1630 transcripts
(p < 0.05, FC ≥ 2.0) on days 1, 2, and 6. Red, gray, and blue represent high, average, and absent expression levels of genes, respectively. Each row
represents one chicken, and each column refers to a gene. 1C, 2C, and 6C indicates days 1, 2 and 6 for the control group respectively, while 1T,
2T, and 6T denotes days 1, 2, and 6 for the thiram-fed group, respectively.
Figure 6 Biological process Gene Ontology (GO) analysis of 82 DEGs on day 1.
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Figure 7 Biological process Gene Ontology (GO) analysis of 1385 DEGs on day 2.
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Figure 8 Biological process Gene Ontology (GO) analysis of 429 DEGs on day 6.
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volved the neuroactive ligand-receptor interaction path-
way. The downregulated genes included chemokine (C-C
motif) receptor 6 (ccr6), prostaglandin E receptor 4
(subtype EP4) (ptger4), arginine vasopressin receptor 2
(avpr2), and proprotein convertase subtilisin/kexin type 5
(pcsk5), while 5-hydroxytryptamine (serotonin) receptor 7
(htr7), and opiate receptor-like 1(oprl1) were upregulated.
Genes screened on day 2 revealed the involvement of
important biological processes such as sterol metabo-
lism, lipid biosynthesis, steroid metabolism, and terpen-
oid backbone biosynthesis in particular. Terpenoid, also
called isoprenoid, plays an important role during cell
growth. Ether lipids, also called plasmalogens or 1-O-alkyl
lipids, are ubiquitous and sometimes form major parts of
cell membranes in mammals. Differences between the
catabolism of ether glycerophospholipids by specific
phospholipases might be involved in the generation of
lipid second messenger systems, which are important in
signal transduction. Ether lipids can also act directly in
cell signaling, as the platelet-activating factor is an ether
lipid signaling molecule that is involved in leukocyte
function in mammalian immune systems. Another pos-
sible function of plasmalogen ether lipids are as antioxi-
dants to protect against oxidative stress, therefore these
lipids might play a role in serum lipoprotein metabolism.
This antioxidant activity comes from the enol ether double
bond that is targeted by a variety of reactive oxygen species
[16]. Sterols are natural active compounds that form major
parts of the cell membranes and are precursors of hormones,
vitamin D and sterol compound. Thus, downregulation in
the expression of synthases is likely to contribute to the pro-
gression of TD.
Analysis of gene expression on day 6 revealed that the
biological processes affected were associated with positive
regulation of developmental processes involved in arachi-
donic acid metabolism and the MAPK signaling pathway.
Arachidonic acid is the direct precursor of active com-
pounds such as prostaglandin E2, prostaglandin I2 and
leukotrienes C4 (LTC4). These play important roles in the
regulation of lipoprotein metabolism, cell development,
blood vessel elasticity and white blood cell function.
From these GO annotations at all time points, we de-
duced that the cytotoxic effects of thiram resulted in
membrane damage, loss of enzymatic activities, and loss
of protein receptor function, especially cysteine-rich pro-
teins. This is likely to influence signal transduction,
thereby leading to cell apoptosis and inhibition of patho-
logical angiogenesis.
Our analyses also suggest that thiram-induced TD at the
early stages is primarily associated with multiple metabolic
pathways, focal adhesion, Jak-STAT, adipocytokine signaling
pathway, GnRH signaling pathway, oxidative phosphoryl-
ation, glycolysis, Wnt, TGF-β, VEGF, and insulin signalingpathways. Metabolic pathways associated with DEGs at
days 2 and 6 were identical. Impaired mitochondrial energy
metabolism occurred during the initial stages of TD, with
glycolysis subsequently induced at later stages of TD. The
focal adhesion and JAK-STAT signaling pathways account
for most DEGs, where focal adhesion and JAK-STAT may
promote chondrocyte proliferation, development, anti-
apoptosis, cell survival, and cell motility through Wnt or
MAPK signaling pathways. During early stages of TD,
many genes were found to have altered expression, due to
the cytotoxic effects of thiram, therefore the proliferation of
growth plate chondrocytes and metabolism were altered.
Horvat-Gordon et al. [17] studied gene expression in
chondrocytes isolated from the proliferative and hyper-
trophic zones of the avian growth plate using microarrays.
They identified a number of genes associated with chon-
drocyte hypertrophy. Our preliminary analyses of the
seven verified DEGs revealed that lysyl oxidase (lox), which
was upregulated, participates in crosslinking of extracellu-
lar collagen via oxidative deamination of lysine or
hydroxylysine [18,19]. LOX also plays important roles in
cell adhesion/proliferation/migration, the intracellular sig-
nal response, and malignant processes. Moreover, LOX re-
enters cells and aggregates around the nuclei after
oxidative changes [20]. The LOX propeptide (LOX-PP) in-
hibits smooth muscle cell signaling and proliferation,
thereby providing a feedback mechanism to inhibit patho-
logical angiogenesis [21]. Heat shock protein 25 (Hsp25)
acts as a molecular chaperone to stabilize proteins [22-24],
maintain membrane integrity, protect nucleic acids, and
stabilize the cytoskeleton [25]. Hsp25 is a marker of differ-
entiated odontoblasts [26-29] and also participates in the
MAPK signaling pathway [30]. Additionally, the roles of
Hsp25 in osteoblast signaling have also been widely stud-
ied [31-34]. The ID-1 protein is a member of the ID pro-
tein family that has been implicated in the regulation of
cellular differentiation, cell cycle progression, senescence,
and apoptosis. Moreover, ID-1 also activates VEGF by en-
hancing the stability and activity of hypoxia-inducible
factor-1a [35,36].
Kinectin 1 (KTN1) is a receptor protein in the reticular
membrane. KTN1 mainly participates in intracellular
vesicle transport and can also regulate protein synthesis
in eukaryotic cells by anchoring the elongation factor-1
complex onto the ER [37]. Tamamura et al. [38] sug-
gested that Wnt/β-catenin signaling regulates chondro-
cyte phenotype, maturation, and function during
cartilage development. Such regulation is critical for
growth plate formation, cartilage boundary definition,
and endochondral ossification. Over-expression of SFRP4
may inhibit the proliferation of osteoblasts by antagoniz-
ing Wnt signaling [39]. SFRP4 may also cause CDH1
over-expression and thus affect cell adhesion and impair
angiogenesis [40]. In addition, hypoxic conditions disrupt
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over-expression [12].Conclusion
We identified global gene expression changes during
early stages of thiram-induced TD. Downregulation of
prostaglandin E receptor 4 (subtype EP4) (ptger4) and
arginine vasopressin receptor 2 (avpr2) on day 1 directly
influenced signal transduction and blood vessel elasticity.
On day 2, downregulation of a variety of synthases altered
the production of lipid compounds that are precursors of
hormones, vitamin D, PTGD, and PTGE, all of which
likely have an important role in angiogenesis, regulation of
transcription and cell proliferation, and bone development.
Taken together, the findings from this study contribute
potential insights into therapies for TD, and also pro-
vide fundamental information regarding the pathological
mechnisms involved during the early stages of TD.Methods
TD induction and tissue collection
Broiler chickens (7 days old) were randomly divided into
two groups. After fasting overnight, animals were fed a
regular diet (control group) or a diet containing 100 mg/kg
thiram for 48 h (thiram-fed group) to induce TD, as previ-
ously described [12]. Eight birds from each group were
sacrificed by cervical dislocation under ether anesthesia on
days 1, 2, and 6 after commencement of the experiment.
The cartilage growth plates from individual birds were
harvested, immediately frozen in liquid nitrogen, and stored
at −70°C. All procedures were performed according toTable 2 Primers used for qPCR analysis
Gene Gene descriptions Primers sequen
lox lysyl oxidase Forward: TACGT
Reverse: TCTCAG
hsp25 heat shock protein 25 Forward: AGGAG
Reverse: GATGCA
id1 inhibitor of DNA binding 1 Forward: GGGGT
Reverse: AGGGG
ktn1 kinectin 1 Forward: CGGTG
Reverse: TGCTAT
sfrp4 secreted frizzled-related protein 4 Forward: GCTGA
Reverse: CTAACA
cdh1 cadherin 1 Forward:TGAGAA
Reverse: GCTCAT
eno2 enolase 2 Forward: GTGTG
Reverse: AGTGCT
rps16 ribosomal protein S16 Forward: ACAAA
Reverse: GCTTTGprotocols approved by the Biological Studies Animal Care
and Use Committee of Hubei Province, China.
Gross and microscopic TD lesions
On days 1, 2 and 6, tibiae were observed and recorded, and
then immediately removed from two groups of chicks.
Samples were fixed overnight in 4% paraformaldehyde or
2.5% glutaraldehyde in phosphate-buffered saline (PBS) at
4°C. Serial histological sections (4-μm thickness) were pre-
pared after samples had been fully decalcified in 10%
ethylenediaminetetraacetic acid (EDTA) decalcifying fluid,
dehydrated, embedded in paraffin wax, and then stained
with hematoxylin and eosin. Sections were examined by
light microscopy. For transmission electron microscopy,
pre-fixed samples were post-fixed in 2% OsO4, dehydrated,
and embedded in epoxy resin. Ultrathin sections were
stained with uranyl acetate and lead citrate, and observed
with a HITACHI H-7650 transmission electron microscope
at 80 kV and a Gatan 832 CCD camera.
RNA extraction
Individual cartilage growth plates collected from each
group of birds were homogenized in TRIzol reagent to ex-
tract total RNA according to an improved method. RNA
integrity and concentration were evaluated using denatur-
ing formaldehyde gel electrophoresis and a Nanodrop
2000 analyzer (Thermo Scientific), respectively.
Microarray hybridization and signal processing
Total RNA samples from18 chickens (three individual
chickens from each group on days 1, 2 and 6) were sent
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(500 ng) was purified using a QIAGEN miRNeasy kit.
The GeneChip IVT Labeling Kit (Affymetrix) was used for
synthesis of biotin-labeled cRNA. Labeled cRNA (15 μg)
was hybridized to the GeneChip Chicken Genome Array
at 45°C for 16 h. GeneChips were washed and stained with
a GeneChip Fluidics Station 450 (Affymetrix) using a
standard protocol, and probe arrays were scanned using a
Scanner 7G. Quality control (QC) data were obtained
using Expression Console software. Principal component
analysis (PCA) and histogram cluster analysis were
conducted with Partek GS 6.4. Identification of DEGs was
also conducted using Partek GS 6.4 through by one way
ANOVA and two way ANOVA. The p-value cutoff for
DEGs was set at 0.05. The adjusted p-value was computed
by the false discovery rate (FDR) using Partek GS 6.4, and
FDR of approximately 5% was set as a threshold. DEGs
were subjected to hierarchical clustering using Cluster
(version 3.0) and visualized with TreeView (version 1.6;
Stanford University). The identified DEGs were ana-
lyzed for GO and biological pathways using DAVID
(http://david.abcc.ncifcrf.gov).
Verification of identified DEGs by qPCR
Total RNA samples used for qPCR verification had also
been used in the microarray analyses. Transcripts from each
sample were amplified in triplicate and detected using a
SYBR Green PCR Master Mix (Applied Biosystems). All
primers used (Table 2) were synthesized by Genery Biotech-
nology. The RPS16 gene was used as the internal control for
normalization, while the reference gene β-actin was used to
verify the differences in expression levels. Data from qPCR
assays were analyzed with Sequence Detector software
(version 1.3.1; Applied Biosystems) and were performed by
a variance analysis (ANOVA). A P-value less than 0.05 was
considered significant.
Additional files
Additional file 1: We identified 1630 transcripts as being
differentially expressed in the growth plate on days 1, 2 and 6 with
one way ANOVA. The 1C, 2C, and 6C designations refer to the control
group on days 1, 2, and 6, respectively. The 1T, 2T, and 6T designations
refer to the thiram-fed group on days 1, 2 and 6, respectively. We have
listed 82 transcripts in sheet 1T vs. 1C, 1385 transcripts in sheet 2T vs. 2C,
and 429 transcripts in sheet 6T vs. 6C. A FC (gene expression level
following administration of the thiram-containing diet compared with
the control) greater than 2.0 represents upregulation, while an FC less
than or equal to 2.0 represents downregulation. Ajusted p value was
computed by the false discovery rate (FDR) of approximately 5% using
Partek GS 6.4.
Additional file 2: We identified 1222 transcripts as being
differentially expressed in the growth plate on days 1, 2 and 6 with
two way ANOVA. The 1C, 2C, and 6C designations refer to the control
group on days 1, 2, and 6, respectively. The 1T, 2T, and 6T designations
refer to the thiram-fed group on days 1, 2 and 6, respectively. We have
listed 39 transcripts in sheet 1T vs. 1C, 1086 transcripts in sheet 2T vs. 2C,and 279 transcripts in sheet 6T vs. 6C. A FC (gene expression level
following administration of the thiram-containing diet compared with
the control) greater than 2.0 represents upregulation, while an FC less
than or equal to 2.0 represents downregulation. Ajusted p value was
computed by the false discovery rate (FDR) of approximately 5% using
Partek GS 6.4.
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